| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/05/1999 | US5856437 Genetic engineering |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856185 Method for making reflection defective retroviral vectors for infecting human cells |
| 01/05/1999 | US5856180 Immortalization of dendritic cells with V-MYC oncogene |
| 01/05/1999 | US5856170 Concerned with the development of an improved vaccine against pneumococcal infections. |
| 01/05/1999 | US5856169 Isolated nucleic acid |
| 01/05/1999 | US5856162 Receptor-type phosphotyrosine phosphatase-κ |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856129 Hydridized detector |
| 01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 01/05/1999 | US5856087 Method for detecting immune response to hepatitis B |
| 01/05/1999 | US5856084 Recombinant dna molecules which code for polypeptides having specificity towards a hepatitis b viral antigen. |
| 01/05/1999 | US5855902 Method of administering a vaccine comprising tritrichomonas foetus membrane surface antigens between 45 and 300 kilopaltons |
| 01/05/1999 | US5855901 Compositions useful for stimulating an immune response to an antigen |
| 01/05/1999 | US5855895 Polyphosphazene polyelectrolyte immunoadjuvants |
| 01/05/1999 | US5855894 Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | US5855887 Lymphocyte activation in response to antigen |
| 01/05/1999 | US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present. |
| 01/05/1999 | US5855880 Avirulent microbes and uses therefor |
| 01/05/1999 | US5855879 Hybrid gramnegative bacteria |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 01/05/1999 | CA2045640C Receptor membranes and ionophore gating |
| 01/05/1999 | CA2045204C Viral decoy vaccine |
| 01/05/1999 | CA1340301C Vaccines against animal parasitic nematodes |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236431A1 Gidb |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059074A1 Human immunodeficiency viruses causing aids in a nonhuman primate |
| 12/30/1998 | WO1998059071A1 Lyme disease vaccines |
| 12/30/1998 | WO1998059064A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059051A1 Recombinant dna which codes for epitopes of the major allergen of olea europaea ole e 1 useful for the diagnosis and treatment of allergies |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998059034A2 Treponema pallidum polynucleotides and sequences |
| 12/30/1998 | WO1998058965A2 B7-binding molecules for treating immune diseases |
| 12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
| 12/30/1998 | WO1998058959A1 Polynucleotides coding for the large subunit of the polymerase of rsvb paramyxovirus |
| 12/30/1998 | WO1998058956A2 Methods for inducing an immune response involving prime-boost protocols |
| 12/30/1998 | WO1998058954A2 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
| 12/30/1998 | WO1998058953A2 Surface exposed proteins from chlamydia pneumoniae |
| 12/30/1998 | WO1998058952A1 Angiotensin derivatives |
| 12/30/1998 | WO1998058951A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
| 12/30/1998 | WO1998058945A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 12/30/1998 | WO1998058943A1 Borrelia burgdorferi polynucleotides and sequences |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 12/30/1998 | WO1998058670A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 12/30/1998 | WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 12/30/1998 | WO1998044944A3 Stabilized human papillomavirus formulations |
| 12/30/1998 | WO1998043670A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887414A2 Human serine proteases HGBAB90 |
| 12/30/1998 | EP0887413A2 Histidine kinase |
| 12/30/1998 | EP0887412A1 Recombinant birnavirus vaccine |
| 12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
| 12/30/1998 | EP0887410A2 DNA encoding a plasminogen activating protein |
| 12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
| 12/30/1998 | EP0886680A1 Virus-like particle |
| 12/30/1998 | EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 12/30/1998 | EP0886646A1 Novel compounds |
| 12/30/1998 | EP0886528A1 Use of coxiella bacteria to treat autoimmune disease |
| 12/30/1998 | EP0886525A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 12/30/1998 | EP0886471A1 Methods and compositions for inducing oral tolerance in mammals |
| 12/30/1998 | EP0750637B1 Dna encoding cai resistance proteins and uses thereof |
| 12/30/1998 | EP0724433B1 Method for preparing microspheres comprising a fluidized bed drying step |
| 12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 12/30/1998 | EP0591384B1 Attenuated revertant serotype 1 marek's disease vaccine |
| 12/30/1998 | EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
| 12/30/1998 | EP0584175B1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| 12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
| 12/30/1998 | EP0539522B1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 12/30/1998 | EP0463059B1 Allergenic proteins from ragweed and uses therefor |
| 12/30/1998 | CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions |
| 12/30/1998 | CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies |
| 12/30/1998 | CN1203275A Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
| 12/30/1998 | CA2304925A1 Borrelia burgdorferi polynucleotides and sequences |
| 12/30/1998 | CA2296814A1 Treponema pallidum polynucleotides and sequences |
| 12/30/1998 | CA2296002A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
| 12/30/1998 | CA2294651A1 Surface exposed proteins from chlamydia pneumoniae |
| 12/30/1998 | CA2294646A1 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells |
| 12/30/1998 | CA2294568A1 Lyme disease vaccines |
| 12/30/1998 | CA2294468A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 12/30/1998 | CA2294348A1 Vaccines containing bordetella pertussis antigen |
| 12/30/1998 | CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |